Zobrazeno 1 - 10
of 156
pro vyhledávání: '"takafumi koyama"'
Publikováno v:
Journal of Arrhythmia, Vol 40, Iss 5, Pp 1171-1174 (2024)
Externí odkaz:
https://doaj.org/article/bea3146fa43c434d80b3bd4d39775964
Autor:
Erisa Fujii, Mayumi Kobayashi Kato, Maiko Yamaguchi, Daiki Higuchi, Takafumi Koyama, Masaaki Komatsu, Ryuji Hamamoto, Mitsuya Ishikawa, Tomoyasu Kato, Takashi Kohno, Kouya Shiraishi, Hiroshi Yoshida
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract The incidence of vulvar carcinoma varies by race; however, it is a rare disease, and its genomic profiles remain largely unknown. This study examined the characteristics of vulvar squamous cell carcinoma (VSCC) in Japanese patients, focusing
Externí odkaz:
https://doaj.org/article/3fd165fe33a246e6aa5ef25c6135f193
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundDrug-induced lung disease (DILD) is a considerable and potentially fatal adverse event with poorly understood risk factors. Large-scale, data-driven analyses investigating regional discrepancies in DILD incidence are lacking. The aim of thi
Externí odkaz:
https://doaj.org/article/c7de1f21921d430fa548fa71b4c56341
Autor:
Yasutoshi Kuboki, Masafumi Ikeda, Shigehisa Kitano, Takafumi Koyama, Noboru Yamamoto, Yuki Yamaguchi, Yuki Nakagawa, Takaaki Ishida, Hidenori Mizugaki, Takatsugu Narikiyo, Ryoko Takubo, Chika Ogami, Mayuko Sekiya
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 7 (2024)
Background Immunosuppressive conditions within the tumor microenvironment (TME) can allow tumors to evade the immune system, including by hampering programmed death ligand 1 (PD-L1) inhibitor activity. Interleukin (IL)-8 contributes to immunosuppress
Externí odkaz:
https://doaj.org/article/3d04b9ef93094c8580ba143d1ba1c0ee
Autor:
Takafumi Koyama, Kazuki Tobita, Tatsuto Kawaguchi, Shuhei Uchida, Eiji Koyama, Nobuhisa Kodera, Yusuke Tamaki, Yuri Otomaru, Hirokazu Miyashita, Takayoshi Yamashita, Shingo Mizuno, Masato Murakami, Shigeru Saito
Publikováno v:
Journal of Arrhythmia, Vol 39, Iss 6, Pp 894-900 (2023)
Abstract Background Previous studies have revealed the risk factors for femoral pseudoaneurysms (FPA). Most data on FPA are based on coronary and peripheral interventions, with limited studies focusing on atrial fibrillation (AF) ablation. However, p
Externí odkaz:
https://doaj.org/article/3df2e6549e3a49638ba752cbcb93d9ae
Autor:
Yasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, Yoichi Naito, Shunsuke Kondo, Kenichi Harano, Kan Yonemori, Kiyotaka Yoh, Yuan Gu, Tetsuya Mita, Xuejun Chen, Eiji Ueda, Noboru Yamamoto, Toshihiko Doi, Toshio Shimizu
Publikováno v:
Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)
Abstract Background Retifanlimab is a humanized monoclonal antibody targeting programmed death protein‐1, and INCB001158 is an oral arginase inhibitor. This phase Ib study investigated retifanlimab, INCB001158, and their combination in Japanese pat
Externí odkaz:
https://doaj.org/article/054b73aa0e9c4d059dd35a08e6fa57cd
Autor:
Takashi Yamada, Masato Murakami, Nobuhisa Kodera, Takahiro Hayashi, Takafumi Koyama, Shingo Mizuno, Shigeru Saito
Publikováno v:
Indian Pacing and Electrophysiology Journal, Vol 23, Iss 5, Pp 144-148 (2023)
Background: Currently, cryoballoon (CB) thawing after single stop is generally performed. Previous research had reported that long thawing time using a single stop affects pulmonary veins tissue injury. However, it is uncertain whether CB thawing aft
Externí odkaz:
https://doaj.org/article/0bdcf40b2e054f42b6a95bb701c7567d
Autor:
Eriku Yamada, Koji Fujita, Takuro Watanabe, Takafumi Koyama, Takuya Ibara, Akiko Yamamoto, Kazuya Tsukamoto, Hidetoshi Kaburagi, Akimoto Nimura, Toshitaka Yoshii, Yuta Sugiura, Atsushi Okawa
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Early detection of cervical myelopathy (CM) is important for a favorable outcome, as its prognosis is poor when left untreated. We developed a screening method for CM using machine learning-based analysis of the drawing behavior of 38 patien
Externí odkaz:
https://doaj.org/article/fa3b5d5e08be4cd5aa36a4541e7579eb
Autor:
Yasutoshi Kuboki, Takako Eguchi Nakajima, Takafumi Koyama, Eriko Sumi, Kotaro Suzuki, Agnish Dey, Hideaki Kagehara, Petar Pop-Damkov, Eiki Maeda, Takenori Akaike, Kondala Atkuri, Masashi Ochi, Ganesh M Mugundu, Aman Singh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/2a19b131d9514d939273cfdd5ff527fa
Autor:
Tempei Miyaji, Yosuke Uchitomi, Maiko Fujimori, Takafumi Koyama, Ayako Sato, Kohei Ogawa, Keita Mori, Makoto Hirata, Ayumu Matsuoka, Masahiro Iwasaku, Noriko Tanabe, Kohei Nakachi, Shunsuke Kato, Hiroaki Okamoto, Hirokazu Komatsu
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Introduction Since May 2019, comprehensive genomic profiling (CGP) has been covered by Japan’s health insurance system for patients with solid tumours that have progressed on standard chemotherapy, rare tumours or tumours of unknown primary origin.
Externí odkaz:
https://doaj.org/article/2df945f1751a4c0489840cac9ff5b4c5